Tag: 上海品茶网TJZ

Mystery solved: The American Hospital Association and CVS Health formed a shadowy, anti-pharma group with deep GOP ties

first_imgPolitics Log In | Learn More Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr. Washington Correspondent Lev Facher covers the politics of health and life sciences. About the Author Reprints WASHINGTON — The dark-money group that has spent over $1 million on mysterious, pharma-bashing radio ads was formed by a top executive and a top lobbyist for the American Hospital Association and a former political consultant for CVS Health, according to a 2018 tax filing released to STAT this week.The secretive group, known as Citizens for Truth in Drug Pricing, has blanketed airwaves with radio advertisements and sponsored commentary that sharply criticizes drug companies for high prices. It has also paid numerous well-known radio hosts, including the conservative personality Hugh Hewitt, to post Facebook ads urging voters to sign a petition to “stop drug companies from overcharging” and warning lawmakers they “risk reelection in 2020” if they do not support drug pricing reforms. GET STARTED Lev Facher @levfacher What’s included?center_img Radio personality Hugh Hewitt Kirk Irwin/Getty Images for SiriusXM Mystery solved: The American Hospital Association and CVS Health formed a shadowy, anti-pharma group with deep GOP ties STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond. What is it? Unlock this article — plus daily intelligence on Capitol Hill and the life sciences industry — by subscribing to STAT+. First 30 days free. GET STARTED By Lev Facher Nov. 20, 2019 Reprints [email protected] Tags drug pricingpolicyPresident TrumpSTAT+White Houselast_img read more

Read More